Non-small-cell lung carcinomas also display high expression of LPAR5, which in turn positively regulates myeloid/lymphoid or mixed-lineage leukaemia, translocated to 11 (MLT11), to stimulate proliferation and migration in vitro as well as tumour growth in vivo [109]. The gene discussed is LPAR5; the disease is neoplasm.